Details for New Drug Application (NDA): 217569
✉ Email this page to a colleague
The generic ingredient in VASOPRESSIN IN SODIUM CHLORIDE 0.9% is vasopressin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 217569
Tradename: | VASOPRESSIN IN SODIUM CHLORIDE 0.9% |
Applicant: | Baxter Hlthcare Corp |
Ingredient: | vasopressin |
Patents: | 0 |
Pharmacology for NDA: 217569
Physiological Effect | Decreased Diuresis Vasoconstriction |
Suppliers and Packaging for NDA: 217569
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VASOPRESSIN IN SODIUM CHLORIDE 0.9% | vasopressin | SOLUTION;INTRAVENOUS | 217569 | NDA | Baxter Healthcare Corporation | 0338-9640 | 0338-9640-12 | 12 BAG in 1 CARTON (0338-9640-12) / 100 mL in 1 BAG |
VASOPRESSIN IN SODIUM CHLORIDE 0.9% | vasopressin | SOLUTION;INTRAVENOUS | 217569 | NDA | Baxter Healthcare Corporation | 0338-9647 | 0338-9647-12 | 12 BAG in 1 CARTON (0338-9647-12) / 100 mL in 1 BAG |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20UNITS/100ML (0.2UNITS/ML) | ||||
Approval Date: | Sep 29, 2023 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 40UNITS/100ML (0.4UNITS/ML) | ||||
Approval Date: | Sep 29, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription